539 related articles for article (PubMed ID: 38617537)
1. Influence of Microbiota on Tumor Immunotherapy.
Yu X; Li W; Li Z; Wu Q; Sun S
Int J Biol Sci; 2024; 20(6):2264-2294. PubMed ID: 38617537
[TBL] [Abstract][Full Text] [Related]
2. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care.
Ciernikova S; Sevcikova A; Drgona L; Mego M
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
Singh RP; Bashir H; Kumar R
Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
[TBL] [Abstract][Full Text] [Related]
4. Host Microbiomes in Tumor Precision Medicine: How far are we?
D'Amico F; Barone M; Tavella T; Rampelli S; Brigidi P; Turroni S
Curr Med Chem; 2022; 29(18):3202-3230. PubMed ID: 34986765
[TBL] [Abstract][Full Text] [Related]
5. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes.
Ting NL; Lau HC; Yu J
Gut; 2022 Jul; 71(7):1412-1425. PubMed ID: 35277453
[TBL] [Abstract][Full Text] [Related]
6. Complex interactions between the microbiome and cancer immune therapy.
Schwartz DJ; Rebeck ON; Dantas G
Crit Rev Clin Lab Sci; 2019 Dec; 56(8):567-585. PubMed ID: 31526274
[TBL] [Abstract][Full Text] [Related]
7. Role of gut microbiome on immunotherapy efficacy in melanoma.
Bibbò S; Ianiro G; Giambò F; Settanni CR; Cammarota G; Gasbarrini A
Hum Vaccin Immunother; 2022 May; 18(3):1926759. PubMed ID: 34190675
[TBL] [Abstract][Full Text] [Related]
8. The triple interactions between gut microbiota, mycobiota and host immunity.
Yang J; Yang H; Li Y
Crit Rev Food Sci Nutr; 2023 Nov; 63(33):11604-11624. PubMed ID: 35776086
[TBL] [Abstract][Full Text] [Related]
9. Exploring the complex and multifaceted interplay of the gut microbiome and cancer prevention and therapy.
Kashyap S; Das A
Acta Microbiol Immunol Hung; 2023 Jun; 70(2):85-99. PubMed ID: 37307215
[TBL] [Abstract][Full Text] [Related]
10. An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome.
Jiang S; Ma W; Ma C; Zhang Z; Zhang W; Zhang J
Gut Microbes; 2024; 16(1):2341717. PubMed ID: 38717360
[TBL] [Abstract][Full Text] [Related]
11. Revealing the therapeutic properties of gut microbiota: transforming cancer immunotherapy from basic to clinical approaches.
Hazra R; Chattopadhyay S; Mallick A; Gayen S; Roy S
Med Oncol; 2024 Jun; 41(7):175. PubMed ID: 38874788
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota in cancer: insights on microbial metabolites and therapeutic strategies.
Chen Y; Wang X; Ye Y; Ren Q
Med Oncol; 2023 Dec; 41(1):25. PubMed ID: 38129370
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy.
Singh A; Alexander SG; Martin S
Front Immunol; 2023; 14():1114499. PubMed ID: 37261348
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect.
Baruch EN; Wang J; Wargo JA
Cancer Immunol Res; 2021 Apr; 9(4):365-370. PubMed ID: 34003768
[TBL] [Abstract][Full Text] [Related]
16. Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications.
Valsecchi AA; Ferrari G; Paratore C; Dionisio R; Vignani F; Sperone P; Vellani G; Novello S; Di Maio M
Crit Rev Oncol Hematol; 2024 May; 197():104328. PubMed ID: 38490281
[TBL] [Abstract][Full Text] [Related]
17. [The Gut Microbiota Metabolite A Enhances the Anti-Tumor Effects of Anti-PD-1 Antibody Therapy through Immune Modulation].
Hosonuma M; Murayama M; Yoshimura K
Gan To Kagaku Ryoho; 2023 Sep; 50(9):960-964. PubMed ID: 37800288
[TBL] [Abstract][Full Text] [Related]
18. The Species of Gut Bacteria Associated with Antitumor Immunity in Cancer Therapy.
Qi X; Liu Y; Hussein S; Choi G; Kimchi ET; Staveley-O'Carroll KF; Li G
Cells; 2022 Nov; 11(22):. PubMed ID: 36429112
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
Lau HCH; Sung JJ; Yu J
Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
[TBL] [Abstract][Full Text] [Related]
20. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
